8:00 AM
State of the Art of Hematology: Emerging Therapies
Ruemu E. Birhiray, MD - Chair
CEO, Indy Hematology Education Inc.,
Partner and Vice President, Hematology Oncology of Indiana, PC

8:30 AM
Benign Hematology
Craig Kessler, MD
Attending Hematologist-Oncologist,
Medstar Georgetown University Hospital,
Professor of Medicine and Pathology
Departments of Medicine and Pathology
Georgetown University Medical Center
(Washington, DC)

9:00 AM
Not So Benign Hematology: A Clinician Primer for 2015
Robert Brodsky, MD
Director, Division of Hematology
Professor of Medicine and Oncology
The Johns Hopkins Family Professor
Johns Hopkins Medicine
(Baltimore, MD)

9:30 AM

9:45 AM
Aggressive B and T Cell Lymphomas
John Leonard, MD
Attending Physician, New York-Presbyterian Hospital, Richard T. Silver Distinguished Professor of Hematology and Medical Oncology, Weill Cornell Medical College (New York, NY)

10:15 AM
Indolent Lymphomas and Hodgkin's Lymphoma
Myron Czuczman, MD
Professor of Medicine, Chief, Lymphoma/Myeloma Service,
Head, Lymphoma Transitional Research Laboratory
Roswell Park Cancer Institute (Buffalo, NY)

10:45 AM
Lymphoma Subsets: Molecular Classification and Drugable Targets
Sonali Smith, MD
Associate Professor, Section of Hematology/Oncology
Director, Lymphoma Program, The University of Chicago (Chicago)

11:15 AM
Multiple Myeloma
Kenneth Anderson, MD
Kraft Family Professor of Medicine, Harvard Medical School
Chief, Division of Hematologic Neoplasia
Dana-Farber Cancer Institute (Boston, Mass.)

11:45 AM
Waldenström's Macroglobulinemia
Steven Treon, MD
Associate Professor, Department of Medicine, Harvard Medical School; Director, Bing Center for Waldenstrom's Macroglobulinemia, Adult Oncology, Dana-Farber Cancer Institute
(Boston, Mass.)

12:15 PM
T-Cell Immunotherapy in Hematologic Malignancies: CARS in the Clinic
David Porter, MD
Jodi Fisher Horowitz Professor of Leukemia Care Excellence
Director, Blood and Marrow Transplantation, University of Pennsylvania Health System
(Philadelphia, Penn.)

1:15 PM

2:00 PM
Myeloproliferative Disorders: What’s new in 2015?
Ayalew Tefferi, MD
Professor of Hematology and Internal Medicine,
Mayo Clinic (Rochester, Minn.)

2:30 PM
Chronic Lymphocytic Leukemia
William Wierda, MD
Professor and Center Director,
Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center (Houston, Texas)

3:00 PM
Chronic Myeloid Leukemia: Imatinib and Beyond
Richard Larson, MD
Professor of Medicine and Director,
Hematologic Malignancies Clinical Research Program, University of Chicago (Chicago)

3:30 PM

3:45 PM
Myelodysplastic Syndrome
Richard Stone, MD
Director, Adult Leukemia Program, Dana-Farber Cancer Institute
Attending Physician, Brigham and Women’s Hospital
Professor of Medicine, Harvard Medical School (Boston, Mass.)

4:15 PM
Acute Leukemia: AML, APL and ALL
Martin Tallman, MD
Chief, Leukemia Service, Memorial Sloan-Kettering Cancer Center
Weill Cornell Medical College (New York, New York)

4:45 PM
Hematopoietic Stem Cell Transplantation
Richard Childs, MD
(Bethesda, Md.)

5:15 PM

5:30 PM

Nursing Symposium Agenda

8:30 AM
Oral Chemotherapy Management
Linda Nielsen, NP
Hematology Oncology of Indiana (Indianapolis, Ind.)

9:30 AM
Benign Hematology
Craig Kessler, MD

10:00 AM
Hematopoietic Stem Cell Transplantation
Richard Childs, MD

10:30 AM
Acute and Chronic Leukemias and MDS
Richard Stone, MD

11:00 AM
Lymphomas and Myeloma
Myron Czuczman, MD